DE
36
-2
OMC
64
-2
SHW
70
2
OXY
55
6
HUM
48
2
CSX
68
3
AMG
43
3
STI
31
19
SE
60
-5
MS
80
-3
RSG
77
4
MMM
42
5
DVA
72
-3
MRO
46
3
DTE
38
-4
EXPE
96
-3
NTAP
61
-3
CAH
60
2
NOC
40
-10
BA
45
-3
DE
36
-2
OMC
64
-2
SHW
70
2
OXY
55
6
HUM
48
2
CSX
68
3
AMG
43
3
STI
31
19
SE
60
-5
MS
80
-3
RSG
77
4
MMM
42
5
DVA
72
-3
MRO
46
3
DTE
38
-4
EXPE
96
-3
NTAP
61
-3
CAH
60
2
NOC
40
-10
BA
45
-3
Financhill
Back

Scilex Holding Vs. Perspective Therapeutics Industry Stock Comparison

Sell
43

SCLX
Scilex Holding

Last Price:
0.68
Seasonality Move:
-3.66%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
43
Scilex Holding (SCLX) is a Sell

Is Scilex Holding a Buy, Sell or Hold?

  • The current Scilex Holding [SCLX] share price is $0.74. The Score for SCLX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SCLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCLX Stock Price Chart

What is Scilex Holding's stock price today?

  • The Scilex Holding share price today is $0.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCLX is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

SCLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 35.21 Sell
Chaikin Money Flow: -1063981 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.82 - 1) Sell
Bollinger Bands (100): (0.86 - 1.6) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: -952055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.27 - 12.77) Sell
Bollinger Bands (100): (11.25 - 14.33) Sell

SCLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.91 Sell
20-day SMA: 0.93 Sell
50-day SMA: 0.93 Sell
200-day SMA: 1.29 Sell
8-day EMA: 0.86 Sell
20-day EMA: 0.9 Sell
50-day EMA: 0.98 Sell
200-day EMA: 1.5 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Sell
20-day SMA: 11.83 Sell
50-day SMA: 12.88 Sell
200-day SMA: 12.8 Sell
8-day EMA: 11.13 Sell
20-day EMA: 11.74 Sell
50-day EMA: 12.46 Sell
200-day EMA: 11.73 Sell

Scilex Holding Earnings Growth & SCLX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.10 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.25 per share.

Scilex Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):